Creso Pharma Ltd
ASX:CPH

Watchlist Manager
Creso Pharma Ltd Logo
Creso Pharma Ltd
ASX:CPH
Watchlist
Price: 0.008 AUD Market Closed
Market Cap: 17.7m AUD

Net Margin
Creso Pharma Ltd

-373.7%
Current
-705%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-373.7%
=
Net Income
-32.8m
/
Revenue
8.8m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
AU
Creso Pharma Ltd
ASX:CPH
17.7m AUD
-374%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
491.8B USD
27%
CH
Roche Holding AG
SIX:ROG
271.4B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP
16%
US
Merck & Co Inc
NYSE:MRK
274.9B USD
30%
CH
Novartis AG
SIX:NOVN
218.8B CHF
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
-126%
US
Pfizer Inc
NYSE:PFE
144.9B USD
16%
No Stocks Found

Creso Pharma Ltd
Glance View

Market Cap
17.7m AUD
Industry
Pharmaceuticals

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

CPH Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-373.7%
=
Net Income
-32.8m
/
Revenue
8.8m
What is the Net Margin of Creso Pharma Ltd?

Based on Creso Pharma Ltd's most recent financial statements, the company has Net Margin of -373.7%.

Back to Top